Amiculum Consulting

AMICULUM is a leading independent global healthcare communications and consultancy group that provides a broad range of services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2001, the organization operates through a cluster of specialized agencies offering expertise in medical communications, clinical trial support, market access, and regulatory affairs. AMICULUM supports clients throughout the product lifecycle, from early-stage development to post-launch commercialization. With a global footprint across Europe, North America, Asia, and the Middle East, the company delivers evidence-based scientific storytelling and strategic consultancy. In 2024, the group received a significant majority investment from the private equity firm Inflexion to support its continued international expansion.